Association of EEG Background and Neurodevelopmental Outcome in Neonates With Hypoxic-Ischemic Encephalopathy Receiving Hypothermia.
Glass. Hannah C HC; Numis. Adam L AL; Comstock. Bryan A BA; Gonzalez. Fernando F FF; Mietzsch. Ulrike U; Bonifacio. Sonia Lomeli SL; Massey. Shavonne S; Thomas. Cameron C; Natarajan. Niranjana N; Mayock. Dennis E DE; Sokol. Gregory M GM; Van Meurs. Krisa P KP; Ahmad. Kaashif A KA; Maitre. Nathalie N; Heagerty. Patrick J PJ; Juul. Sandra E SE; Wu. Yvonne W YW; Wusthoff. Courtney J CJ
Key Findings
- EEG background patterns can be classified into normal, discontinuous, or severely abnormal during therapeutic hypothermia.
- The more severe the EEG abnormality, the higher the risk of death or neurodevelopmental impairment (NDI) by age 2.
- Severe EEG abnormalities at any time point increased the adjusted relative risk of death or severe NDI to about 8‑fold.
Practical Outcomes
- For biohackers and self‑experimenters, this study offers little direct, actionable insight because it focuses on neonatal intensive care and a medical intervention (therapeutic hypothermia) not relevant to adult health optimization. The main takeaway is that EEG can be a powerful early biomarker for brain injury outcomes, but it does not translate into protocols or dosage guidance for longevity or performance enhancement.
Summary
In newborns who suffered oxygen loss to the brain and were cooled to protect them, the pattern of brain waves (EEG) recorded during treatment predicts how well they will develop by age two. Babies with very abnormal EEG patterns were far more likely to die or have serious developmental problems.
Abstract
Predicting neurodevelopmental outcome for neonates with hypoxic-ischemic encephalopathy (HIE) is important for clinical decision-making, care planning, and parent communication. We examined the relationship between EEG background and neurodevelopmental outcome among children enrolled in a trial of erythropoietin or placebo for neonates with HIE treated with therapeutic hypothermia. Participants had EEG recorded throughout hypothermia. EEG background was classified as normal, discontinuous, or severely abnormal (defined as burst suppression, low voltage suppressed, or status epilepticus) at 5 1-hour epochs: onset of recording, 24, 36, 48, and 72 hours after birth. The predominant background pattern during the entire continuous video EEG monitoring recording was calculated using the arithmetic mean of the 5 EEG background ratings (normal = 0; discontinuous = 1; severely abnormal = 2) as follows: "predominantly normal" (mean = 0), "normal/discontinuous" (0 < mean<1), "predominantly discontinuous" (mean = 1), "discontinuous/severely abnormal" (1 < mean<2), or "predominantly severely abnormal" (mean = 2). Primary outcome was death or neurodevelopmental impairment (NDI) defined as cerebral palsy, Gross Motor Function Classification Score ≥1, or cognitive score <90 on Bayley Scales of Infant Toddler Development, third edition at age 2 years. Neurodevelopment was also categorized into a 5-level ordinal measure: no, mild, moderate, severe NDI, or death for secondary analysis. We used generalized linear regression models with robust standard errors to assess the relative risk of death or NDI by EEG background in both unadjusted and adjusted analyses controlling for the effects of treatment group, sex, HIE severity, and study recruitment site. Among 142 neonates, the predominant background EEG pattern was predominantly normal in 35 (25%), normal/discontinuous in 68 (48%), predominantly discontinuous in 11 (7.7%), discontinuous/severely abnormal in 16 (11%), and predominantly severely abnormal in 12 (8.5%). Increasing severity of background across monitoring epochs was associated with increasingly worse clinical outcomes. Children with severe EEG background abnormality at any time point (n = 36, 25%) were significantly more likely to die or have severe NDI at 2 years (adjusted relative risk: 7.95, 95% CI 3.49-18.12). EEG background is strongly associated with NDI at age 2 years. These results can be used to assist health care providers to plan follow-up care and counsel families for decision-making related to goals of care.
Study Information
pubmed
2023
2023-11-27T00:00:00.000Z
10.1212/wnl.0000000000207744